Skip to content
HeyJared

Strategy& Insider

The Strategy& Insider podcast aims to explore some of the most critical future trends and their impacts. Strategy& talks to industry experts and leading practitioners from different sectors.

Podcast · By Thomas Solbach, Ghioia Irritier, Jan-Philipp Loch · English · Official site

Indexed episodes, last 90 days
3
Latest publication
Sep 23, 2026
Audience
Checking…
Earliest in this view
Jul 22, 2026

Latest episodes

  1. Episode · Sep 23, 2026

    Strategy& Insider Episode 50 - Empowering an AI-enabled clinician (opens the original)

    Episode notes · Positive tone

    Read excerpt

    Dr. Ami Bhatt, Chief Medical Officer at WHOOP and inaugural chair of the U.S. FDA's Digital Health Advisory Committee, joins the show for the 50th anniversary episode to explore how AI, wearable technology, and equity-first design are transforming healthcare. From the "AI-enabled clinician" to closing gender gaps in heart health and rethinking regulation as scaffolding for innovation rather than a barrier, this episode offers a compelling vision for a smarter, more human healthcare system. Disco

  2. Episode · Aug 26, 2026

    Strategy& Insider Episode 49 - Reinventing the hospital with AI and robotics (opens the original)

    Episode notes · Positive tone

    Read excerpt

    Dr. Jorge Short Apellániz, Manager of the Rey Juan Carlos University Hospital which is part of Quirónsalud, one of Europe's leading hospital networks, explains how AI, robotics, and digital platforms can fundamentally reshape how care is delivered. Recorded in Madrid at University Hospital Rey Juan Carlos, this episode explores why the future of healthcare is not about technology alone but about connecting care across the entire patient journey – before, during, and after treatment. Jorge shares

  3. Episode · Jul 22, 2026

    Strategy& Insider Episode 48 - Rewriting medicine with CRISPR and genome editing (opens the original)

    Episode notes · Positive tone

    Read excerpt

    What if curing a disease took a single treatment instead of a lifetime of pills, and the same technology could help cool the planet? In this episode, Dr. Bradley Ringeisen, Executive Director of the Innovative Genomics Institute (IGI) at UC Berkeley, takes us inside the CRISPR revolution. From the first FDA-approved sickle cell therapy to a custom cure that saved a baby's life in Philadelphia, to rice engineered to emit 60% less methane, Brad reveals how genome editing is reshaping medicine, cli

Publishing over time

Last 90 days. Choose a month to open its work.

Recurring subjects

Named in the text we hold. One piece can cover several.

Audience

No verified audience measurement yet.

About this data

Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.

Identity or attribution wrong? Suggest a correction.

See coverage about Strategy& Insider